VILTEPSO (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy (DMD)

VILTEPSO (viltolarsen) injection is the second FDA-approved targeted treatment for patients with DMD after Sarepta’s Vyondys 53 (golodirsen) injection. Credit: NS Pharma, Inc.



  • VILTEPSO
  • VILTEPSO
  • VILTEPSO